Healthcare
Wednesday, March 30, 2016
BRIEF-Rxi Pharmaceuticals reports Q4 loss per share of $0.04
* Rxi pharmaceuticals reports fourth quarter and year end 2015 financial results and recent corporate highlights
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment